At least 16,183 people say they’ve developed tinnitus after receiving a COVID-19 shot.1,2 The reports were filed with the U.S. Centers for Disease Control and Prevention’s Vaccine Adverse Event Reporting System (VAERS) database. But considering only between 1%3 and 10%4 of adverse reactions are ever reported to VAERS, the actual number is likely much higher.… Read More »
Pfizer’s Paxlovid was granted emergency use authorization to treat mild to moderate COVID-19 in December 2021.1 The drug consists of nirmatrelvir tablets — the antiviral component — and ritonavir tablets, which are intended to slow the breakdown of nirmatrelvir.2 What started out as a slow rollout — only 40,000 or fewer prescriptions were written for… Read More »
A new study involving the Pfizer-BioNTech COVID-19 vaccine suggests the jab’s efficacy drops to around 84% about six months after the second dose. The study, which has not yet been peer-reviewed and was published on medRxiv, was supported by Pfizer and BioNTech, concluding that despite “a gradually declining trend in vaccine efficacy,” it still was… Read More »
Along with the police and other security forces, the army will be back on the streets to ensure no one breaches the stay-at-home guidance without an emergency reason from 6am to Aug 5 midnight. There were speculations that the government would defer the lockdown, but State Minister for Public Administration Farhad Hossain on Thursday confirmed… Read More »
Smokers looking for Pfizer’s cessation med Chantix may have a tough time finding the drug as the pharma giant has halted global distribution on impurity concerns. After finding unacceptable levels of potential carcinogens called nitrosamines in certain Chantix lots, Pfizer has halted worldwide distribution of the popular smoking cessation medicine. A spokesman said the company believes the… Read More »